Your browser is no longer supported. Please, upgrade your browser.
Hepion Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.20 Insider Own0.14% Shs Outstand76.22M Perf Week-2.52%
Market Cap117.37M Forward P/E- EPS next Y-0.56 Insider Trans0.00% Shs Float76.12M Perf Month1.97%
Income-24.90M PEG- EPS next Q- Inst Own21.50% Short Float2.35% Perf Quarter-31.42%
Sales- P/S- EPS this Y65.60% Inst Trans-10.76% Short Ratio1.00 Perf Half Y-18.42%
Book/sh1.43 P/B1.08 EPS next Y-55.60% ROA-31.90% Target Price- Perf Year-46.55%
Cash/sh1.45 P/C1.07 EPS next 5Y- ROE-36.30% 52W Range1.36 - 3.69 Perf YTD-29.22%
Dividend- P/FCF- EPS past 5Y64.10% ROI- 52W High-57.99% Beta1.17
Dividend %- Quick Ratio16.00 Sales past 5Y- Gross Margin- 52W Low13.98% ATR0.08
Employees13 Current Ratio16.00 Sales Q/Q- Oper. Margin- RSI (14)47.05 Volatility4.14% 5.77%
OptionableYes Debt/Eq0.00 EPS Q/Q82.70% Profit Margin- Rel Volume0.38 Prev Close1.58
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.78M Price1.55
Recom2.00 SMA20-3.34% SMA500.22% SMA200-17.89% Volume677,918 Change-1.90%
Jul-20-20Resumed ROTH Capital Buy $14
Sep-13-21 08:00AM  
Sep-10-21 04:05PM  
Aug-15-21 05:50AM  
Jul-23-21 04:40PM  
Jul-13-21 08:00AM  
Jun-25-21 04:30PM  
Jun-09-21 07:45AM  
May-16-21 05:10AM  
May-06-21 07:45AM  
Apr-29-21 09:50AM  
Mar-23-21 07:15AM  
Mar-22-21 04:30PM  
Mar-11-21 07:30AM  
Feb-18-21 04:30PM  
Feb-16-21 06:45AM  
Feb-12-21 04:45PM  
Feb-10-21 07:30AM  
Feb-09-21 04:30PM  
Feb-05-21 02:00AM  
Jan-29-21 03:07PM  
Jan-05-21 08:00AM  
Dec-29-20 04:15PM  
Dec-22-20 07:30AM  
Dec-10-20 08:55AM  
Dec-02-20 07:30AM  
Nov-30-20 05:30PM  
Nov-24-20 07:20PM  
Nov-18-20 07:30AM  
Nov-17-20 04:30PM  
Nov-12-20 08:30AM  
Nov-10-20 09:00AM  
Nov-05-20 08:57AM  
Oct-27-20 07:45AM  
Oct-05-20 07:30AM  
Sep-29-20 08:30AM  
Sep-17-20 08:00AM  
Sep-01-20 07:30AM  
Aug-27-20 07:15AM  
Aug-12-20 07:15AM  
Aug-05-20 07:15AM  
Jul-07-20 07:30AM  
Jun-29-20 04:15PM  
Jun-22-20 04:15PM  
Jun-10-20 04:15PM  
May-20-20 04:15PM  
May-19-20 07:00AM  
Mar-12-20 08:15AM  
Feb-19-20 04:30PM  
Feb-12-20 04:15PM  
Jan-28-20 04:15PM  
Jan-08-20 04:15PM  
Jan-06-20 04:15PM  
Dec-23-19 11:17AM  
Dec-12-19 11:42AM  
Dec-11-19 09:08AM  
Dec-10-19 04:20PM  
Dec-09-19 04:15PM  
Dec-03-19 04:15PM  
Nov-21-19 09:01AM  
Nov-20-19 04:15PM  
Nov-07-19 04:15PM  
Oct-23-19 04:15PM  
Oct-16-19 04:15PM  
Oct-10-19 08:00AM  
Oct-03-19 04:15PM  
Sep-04-19 08:30AM  
Sep-03-19 04:30PM  
Aug-14-19 08:30AM  
Aug-07-19 01:00PM  
Jul-31-19 09:20AM  
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cavan John TChief Financial OfficerFeb 18Buy2.0010,00020,00014,800Feb 18 04:05 PM
Foster Robert TCEO and DirectorFeb 18Buy2.0020,00040,00045,259Feb 18 04:05 PM
Wijngaard PeterDirectorFeb 16Buy2.2010,00022,00030,000Feb 18 04:06 PM
Wijngaard PeterDirectorDec 18Buy1.9120,00038,20020,000Dec 21 09:17 AM
Foster Robert TCEO and DirectorDec 08Buy1.5825,00039,41825,259Dec 08 01:56 PM
BRANCACCIO JOHN PDirectorDec 02Buy1.537,00010,7107,008Dec 02 06:05 PM
JACOB GARY SDirectorDec 01Buy1.6612,00019,92012,059Dec 01 07:53 PM
Cavan John TChief Financial OfficerNov 25Buy1.624,5007,2904,800Nov 30 04:53 PM